Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 7, 2011, Pages 1350-1357

  Grotmol, Tom ^a   Bray, Freddie ^a,b,e   Holte, Harald ^d   Haugen, Marion ^b   Kunz, Lauren ^b   Tretli, Steinar ^a   Aalen, Odd O ^b   Moger, Tron A ^b,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b Institute of Basic Medical Sciences   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION; PRIORITY JOURNAL; SEX;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; FINLAND; HODGKIN DISEASE; HUMANS; ICELAND; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NORWAY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 79960108957     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1014     Document Type: Article

References (34)

1. MacMahon B. Epidemiological evidence of the nature of Hodgkin's disease. Cancer 1957;10:1045-54.
2. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-201.
3. Mueller N. Hodgkin's disease. In:Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention New York: Oxford University Press; 1996. p. 893-919.
4. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108:3786-91. (Pubitemid 44864560)
5. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987;129:86-91. (Pubitemid 17157773)
6. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med 2008;264:537-48.
7. Jarrett RF. Viruses and lymphoma/leukaemia. J Pathol 2006;208:176-86. (Pubitemid 43126111)
8. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
9. Meza R, Jeon J, Moolgavkar SH, Luebeck EG. Age-specific incidence of cancer: Phases, transitions, and biological implications. Proc Natl Acad Sci U S A 2008;105:16284-9.
10. Aalen OO, Tretli S. Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 1999;10:285-92. (Pubitemid 29360404)
11. Moger TA, Aalen OO, Halvorsen TO, Storm HH, Tretli S. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 2004;5:1-14. (Pubitemid 41180232)
12. Svensson E, Moger TA, Tretli S, Aalen OO, Grotmol T. Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. Eur J Epidemiol 2006;21:587-93. (Pubitemid 44546620)
13. Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T. Ageincidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 2008;17:2356-65.
14. Haugen M, Bray F, Grotmol T, Tretli S, Aalen OO, Moger TA. Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations. Biostatistics 2009;10:501-14.
15. www.ancr.nu
16. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010;49:725-36.
17. Aalen OO, Borgan Ø, Gjessing HK. Unobserved heterogeneity: The odd effects of frailty. In:Survival and event history analysis: a process point of view New York: Springer-Verlag; 2008. p. 231-70.
18. Stata Statistical Software, College StationStataCorp, editor, TX, StataCorp LP; 2009.
19. R: A language and environment for statistical computingR development Core Teameditor, Vienna, R Foundation for Statistical Computing; 2008.
20. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974;19:716-23.
21. Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12:1272-6. (Pubitemid 28395991)
22. Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007;21:825-40 (Pubitemid 47496094)
23. Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983;70:167-92. (Pubitemid 13008988)
24. Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 2005;365:2216-24. (Pubitemid 40853915)
25. Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 2010;107:6400-5.
26. Broderick P, Cunningham D, Vijayakrishnan J, Cooke R, Ashworth A, Swerdlow A, et al. IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma. Br J Haematol 2010;148:413-5.
27. Lourenço GJ, Néri IA, Sforni VC, Kameo R, Lorand-Metze I, Lima CS. Polymorphisms of glutathione S-transferase Mu 1, glutathione S-transferase theta 1 and glutathione S-transferase Pi 1 genes in Hodgkin's lymphoma susceptibility and progression. Leuk Lymphoma 2009;50:1005-9.
28. El-Zein R, Monroy CM, Etzel CJ, Cortes AC, Xing Y, Collier AL, et al. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer 2009;115:1651-9.
29. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992- 2001. Blood 2006;107:265-76.
30. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variants create synthetic genome-wide associations. PLoS Biol 2010;8:e1000294.
31. Frank SA, Nowak MA. Developmental predisposition to cancer. Nature 2003;422:494. (Pubitemid 36433638)
32. Morgan G, Vornanen M, Puitinen J, Naukkarinen A, Brincker H, Olsen J, et al. Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group. Ann Oncol 1997;8 Suppl 2:49-54.
33. Foss Abrahamsen A, Egeland T, Hansen S, Langholm R, Holte H, Kvaløy S. Hodgkin's disease in a national and hospital population: trends over 20 years. Eur J Cancer 1997;33:2380-3. (Pubitemid 28129180)
34. Byrne HM. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 2010;10:221-30.